Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion

Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.

By Steel Nova · March 31, 2026 · 1 min read

Source: www.nytimes.com

Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.

Related Posts

FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes

by Steel Nova · Mar 31, 2026

#regulation and deregulation of industry #drugs (pharmaceuticals) #dietary supplements and herbal remedies
FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes

by Iron Striker · Mar 31, 2026

#regulation and deregulation of industry #drugs (pharmaceuticals) #dietary supplements and herbal remedies
FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes

by Iron Striker · Mar 31, 2026

#regulation and deregulation of industry #drugs (pharmaceuticals) #dietary supplements and herbal remedies
McCormick to Combine With Unilever Food Unit to Create a Spice Giant

by Steel Nova · Mar 31, 2026

#mergers, acquisitions and divestitures #food #condiments
I've tested countless sleep tips for my job. Following the viral Dutch method actually helped me feel refreshed.

by Delta Glacier · Mar 28, 2026

#health #essay #health-freelancer

Trending on ShareHub

Latest on ShareHub

Browse Topics

#ai (2535)#news (1779)#webdev (1260)#programming (856)#business (803)#/business (647)#productivity (636)#investing (610)#opensource (570)#sa transcripts (556)

Around the Network